Resultats de la cerca - Anita K. Wagner

30 years of media coverage on high drug prices in the US - a never-ending story or a time for change? per Christine Leopold, James D Chambers, Anita K Wagner

Connect to this object online.

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand per Christine Leopold, Christine Y. Lu, Anita K. Wagner

Connect to this object online.

Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway per Mahnum Shahzad, Huseyin Naci, Katharine M. Esselen, Joseph A. Dottino, Anita K. Wagner

Connect to this object online.

1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities per Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner, Dennis Ross-Degnan

Connect to this object online.

The Brazilian private pharmaceutical market after the first ten years of the generics law per Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan

Connect to this object online.

Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020Research in context per Yuxuan Wei, Yichen Zhang, Ziyue Xu, Guoan Wang, Yue Zhou, Huangqianyu Li, Luwen Shi, Huseyin Naci, Anita K. Wagner, Xiaodong Guan

Connect to this object online.

Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context per Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-, Sabine Vogler, Elias Mossialos, Carla L. Tavares-, Huseyin Naci

Connect to this object online.

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries per Christine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, Silvia Valkova, Kees de Joncheere, Hubert GM Leufkens, Anita K Wagner, Dennis Ross-Degnan, Richard Laing

Connect to this object online.

Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China per Dr. Yu Fang, PhD, Anita K Wagner, DrPH, Shimin Yang, BS, Minghuan Jiang, MS, Fang Zhang, PhD, Dennis Ross-Degnan, ScD

Connect to this object online.